Paediatric Hodgkin's disease

European Journal of Cancer

Volumn 35, Issue 10, 1999, Pages 1466-1474

  Potter R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; DISEASE CLASSIFICATION; HODGKIN DISEASE; HUMAN; IMAGING; INCIDENCE; MEDICAL RESEARCH; PRIORITY JOURNAL; REMISSION; REVIEW;

EID: 0345062241     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00117-3     Document Type: Article

References (96)

1. Glaser S.L., Jarrett R.F. The epidemiology of Hodgkin's disease. Diehl V. Hodgkin's Disease Baillière's Clinical Haematology Vol. 9, No. 3. 1996;401-417 Baillère Tindall, London.
2. Jarrett A.F., Armstrong A.A., Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann. Oncol. 7:1996;5-10.
3. Hodgkin T. On some morbid appearances of the absorbant glands and spleen. Med. Chir. Trans. 17:1832;68-114.
4. Reed D.M. On the pathological changes in Hodgkin's disease, with special reference to its relation to tuberculosis. Johns Hopkins Hosp. Rev. 10:1902;133-196.
5. Sternberg C. Über die eigenartige, unter dem bilde der pseudoleukämie verlaufende tuberculose des lymphatischen apparates. Z. Heilk. 19:1898;21-90.
6. Lukes R., Butler J., Hicks E. Natural history of Hodgkin's disease as related to its pathological picture. Cancer. 19:1966;317-344.
7. Harris N.L., Jaffe E.S., Stein H.et al. A revised European-American classification of lymphoid neoplasms. a proposal from the International Lympoma Study Group Blood. 84:1994;1361-1392.
8. Bennett M.H., MacLennan K.A., Easterling M.J., Vaughan Hudson B., Vaughan Hudson G., Jelliffe A.M. Analysis of histological subtypes in Hodgkin's disease in relation to prognosis and survival. Quaglino D., Hayhoe F.G.J. The Cytobiology of Leukaemias and Lymphomas. 1985;15 Raven Press, New York.
9. Braeuninger A., Kuppers R., Strickler J.G., Wacker H.H., Rajewsky K., Hansmann M.L. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumour B cells. Proc. Natl. Acad. Sci. USA. 94:1997;9337-9342.
10. Pan L.X., Diss T.C., Peng H.Z., Norton A.J., Isaacson P.G. Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder? Blood. 87:1996;2428-2434.
11. Kamel O.W., Chang P.P., Hsu F.J., Dolezal M.V., Warnke R.A., van de Rijn M. Clonal VDJ recombination of the immunoglobulin heavy chain gene by PCR in classical Hodgkin's disease. Am. J. Clin. Pathol. 104:1995;419-423.
12. Manzanal A.I., Santon A., Acevedo A., Aguilera B., Oliva H., Bellas C. Molecular analysis of the IgH gene in 212 cases of Hodgkin's disease. correlation of IgH clonality with the histologic and the immunocytochemical features Mod. Pathol. 10:1997;679-685.
13. Delabie J., Tierens A., Gavriil T., Wu G., Weisenburger D.D., Chan W.C. Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: results of a single cell study. Br. J. Haematol. 94:1996;198-205.
14. Kanzler H., Kuppers R., Hansmann M.L., Rajewsky K. Hodgkin, Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1996;1495-1505.
15. Papadimitriou C.S., Bai M.K., Kotsianti A.J., Costopoulos J.S., Hytiroglou P. Phenotype of Hodgkin and Sternberg-Reed cells and expression of CD57 (LEU7) antigen. Leuk. Lymphoma. 20:1995;125-130.
16. Gupta R.K., Lister T.A., Bodmer J.G. The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease. Leukemia. 8:1994;1337-1341.
17. Hsu S.M., Hsu P.L. The nature of Reed-Sternberg cells. phenotype, genotype and other properties Crit. Rev. Oncog. 5:1994;213-245.
18. Bargou R.C., Leng C., Krappmann D.et al. High-level nuclear NF-kappa B and Oct2 is a common feature of cultured Hodgkin/Reed-Sternberg cell. Blood. 87:1996;4340-4347.
19. Bargou R.C., Emmerich F., Krappmann D.et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:1997;2961-2969.
20. Herbst N., Niedobitek G. Epstein-Barr virus and Hodgkin's disease. Int. J. Clin. Lab. Res. 23:1994;13-18.
21. Jiwa N.M., Oudejans J.J., Bai M.C.et al. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease. implications for different pathogenic mechanisms (see comments) Histopathology. 26:1995;547-553.
22. Messineo C., Jamerson M.H., Hunter E., Braziel R., Bagg A., Irving S.G., Cossmann J. Gene expression by single Reed-Sternberg cells. pathways of apoptosis and activation Blood. 91:1998;2443-2451.
23. Dewey W.C., Clifton C.L., Meyn R.E. Radiation induced apoptosis. relevance to radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 33:1995;781-790.
24. Carbone P.P., Kaplan H.S., Musshoff K.et al. Report of the committe on Hodgkin's disease staging classification. Cancer Research. 31:1971;1860-1861.
25. Mendenhall N.P., Cantor A.B., Williams J.L.et al. With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group Study. J. Clin. Oncol. 11:1993;2218-2225.
26. Baker L.L., Parker B.R., Donaldson S.S. Staging of Hodgkin Disease in children. comparison of CT and lymphography with laparotomy AJR. 154:1990;1251-1255.
27. Hays D.M., Fryer C.J., Pringle K.C.et al. An evaluation of abdominal staging procedures performed in pediatric patients with advanced Hodgkin's disease. a report from the Childrens Cancer Study Group J. Ped. Surg. 27:1992;1175-1180.
28. Schellong G., Lietzke S., Strauch S., Kuhne B., Schneider B. Bedeutung sonographischer, computertomographischer und klinischer befunde für die erkennung eines abdominalbefalls beim morbus Hodgkin im kindesalter - eine retrospektive statistische analyse bei 145 patienten der therapiestudie DAL-HD-82. Klin. Pädiat. 198:1986;147-154.
29. Lister T.A., Crowther D., Sutcliffe S.B.et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease. Cotswolds Meeting J. Clin. Oncol. 7:1989;1630-1636.
30. Carde P. Diagnostic procedures. Diehl V. Hodgkin's Disease. Baillière's Clinical Haematology Vol 9, No. 3. 1996;479-501 Baillère Tindall, London.
31. Skillings J.R., Bramwell V., Nicholson R.L.et al. A prospective study of magnetic resonance imaging in lymphoma staging. Cancer. 67:1991;1838-1843.
32. Hagemeister F.B., Fesus S.M., Lamki L.M., Haynie T.P. Role of the gallium scan in Hodgkin's disease. Cancer. 65:1990;1090-1096.
33. Pötter R, Dieckmann K, Hofmann J, et al. Individualisation of radiation fields based on modern sectional imaging within combination treatment of pediatric Hodgkin's Disease (HD): evaluation of 386 patients from the German-Austrian multicenter trial (HD-90). Int J Radiat Oncol Biol Phys 1995, 32(Supp1.), Abstract 81.
34. Pusey W.A. Cases of sarcoma and of Hodgkin's Disease treated by exposure to X-Rays - a preliminary report. J.A.M.A. 38:1902;166-169.
35. Holzknecht G. Drüsentumoren. Wiener klinische Wochenschrift. 1905, 418.
36. Gilbert R. Radiotherapy in Hodgkin's Disease (malignant granulomatosis). Anatomic and clinical foundations; governing principles; results. Am. J. Roent. and Radium Therapy. 41:1939;198-241.
37. Peters V. A Study of Survivals in Hodgkin's Disease treated radiologically. Am. J. Roent. and Radium Therapy. 63:1950;299-311.
38. Peters V. Prophylactic treatment of adjacent areas in Hodgkin's disease. Cancer Research. 26:1966;1232-1243.
39. Kaplan H.S. The radical radiotherapy of regionally localized Hodgkin's disease. Radiology. 78:1962;553-561.
40. DeVita V.T., Serpick A., Carbone P.P. Combination therapy in the treatment of advanced HD. Ann. Inter. Med. 73:1970;881-895.
41. Bonadonna G., Zucali R., Monfardini S.et al. Combination chemotherapy of Hodgkin's Disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 36:1975;252-259.
42. Donaldson S.S., Glatstein E., Rosenberg S.A.et al. Pediatric Hodgkin's disease. II. Results of therapy Cancer. 37:1976;2436-2447.
43. Probert J.C., Parker B.R. The effects of radiation therapy on bone growth. Radiology. 114:1975;115-162.
44. Jenkin D., Doyle J., Berry M.et al. Hodgkin's disease in children. treatment with MOPP and low-dose, extended field irradiation without laparotomoy. Late results and toxicity Med. Ped. Oncol. 18:1990;265-272.
45. Jenkin R.D.T., Chan H., Freedman M.et al. Hodgkin's disease in children. treatment results with MOPP and low dose extended-field irradiation Cancer Treat. Rep. 66:1982;439-459.
46. Vecchi V., Pileri St., Burnelli R.et al. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. Cancer. 72:1993;2049-2057.
47. Weiner M.A., Leventhal B.G., Marcus R.et al. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients. a Pediatric Oncology Group Study J. Clin. Oncol. 9:1991;1591-1598.
48. Breu H., Schellong G., Grosch-Wörner I.et al. Abgestufte chemotherapie und reduzierte strahlendosis beim morbus Hodgkin im kindesalter - ein bericht über 170 patienten der kooperativen therapiestudie HD 78. Klin. Pädiat. 194:1982;233-241.
49. Fossati-Bellani F, Gasparini M, Kenda A, et al. Limited field and low-dose radiotherapy+ABVD chemotherapy for childhood Hodgkin's disease. Abstract XVIIth SIOP Meeting, Venice 1985, 323-324.
50. Donaldson S.S., Link M.P. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J. Clin. Oncol. 5:1987;742-749.
51. Fryer C.J., Hutchinson J.R., Krailo M.et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Childrens Cancer Study Group. J. Clin. Oncol. 12:1990;1971-1980.
52. Gehan E.A., Sullivan M.P., Fuller L.M.et al. The intergroup Hodgkin's Disease in Children. Cancer. 65:1990;1429-1437.
53. Oberlin O., Boilletot A., Leverger G., Sarrazin D., Lemerle J. Clinical staging, primary chemotherapy and involved field radiotherapy in childhood Hodgkin's disease. Eur. Paed. Haematol. Oncol. 2:1985;65-70.
54. Schellong G., Brämswig J., Ludwig R.et al. Kombinierte behandlungsstrategie bei über 200 kindern mit morbus Hodgkin: abgestufte chemotherapie, involved-field-bestrahlung mit erniedrigten dosen und selektive splenektomie. Klin. Pädiat. 198:1986;137-146.
55. Behrendt H., van Bunningen B., van Leeuwen E.F. Treatment of HD in children without radiotherapy. Cancer. 59:1987;1870-1873.
56. Radford M., Barrett A., Martin J., Cotterill S. Treatment of Hodgkin's disease in children. Study HDI. Med. Ped. Oncol. 19:1991;400.
57. Barrett A., Crennan E., Barnes J.et al. Treatment of clinical stage I Hodgkin's disease by local radiation therapy alone. Cancer. 66:1990;670-674.
58. Jereb B., Tan C., Bretsky S., He S.Q., Exelby P. Involved field (IF) irradiation with or without chemotherapy in the management of children with Hodgkin's disease. Med. Ped. Oncol. 12:1984;325-332.
59. Meadows A.T., Obringer A., Marrero O.et al. Second malignant neoplasms following childhood Hodgkin's disease. treatment and splenectomy as risk factors Med. Ped. Oncol. 17:1989;477-484.
60. Brämswig J.H., Heimes U., Heiermann E.et al. The effects of different cumulative doses of chemotherapy on testicular function. Cancer. 65:1990;1298-1302.
61. Donaldson S.S., Kaplan H.S. Complications of treatment of Hodgkin's disease in children. Cancer Treat. Rep. 66:1982;977-989.
62. Hancock S.L., Tucker M.A., Hoppe R.T. Breast cancer after treatment of Hodgkin's disease. J. Natl. Cancer Inst. 85:1993;25-31.
63. Bhatia S., Robison L.L., Oberlin O.et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 21:1996;745-751.
64. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA. 270:1993;1949-1955.
65. Mefferd J.M., Donaldson S.S., Link M.P. Pediatric Hodgkin's disease. Pulmonary, cardiac and thyroid function following combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;679-685.
66. Constine L.S., Donaldson S.S., McDougall R., Cox R.S., Links M.P., Kaplan H.S. Thyroid dysfuncion after radiotherapy in children with Hodgkin's disease. Cancer. 53:1984;878-883.
67. Hudson MM, Poquette C, Luo X, et al. Fatal late events after treatment for pediatric Hodgkin's disease. Med Pediatr Oncol 1997, 29, Abstract O-63.
68. Schellong G. Treatment of children and adolescents with Hodgkin's Disease. the experience of the German-Austrian Paediatric Study Group Diehl V. Hodgkin's Disease. Baillière's Clinical Haematology Vol 9, No. 3. 1996;619-634 Baillère Tindall, London.
69. Jenkin R.D.T., Brown T.C., Peters M.V., Sonley M.J. Hodgkin's Disease in Children. A retrospective analysis. 1958-73 Cancer. 35:1975;979-990.
70. Dionet C., Oberlin O., Habrand J.L.et al. Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease. results of a joint cooperative study by The French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris Int. J. Radiat. Oncol. Biol. Phys. 15:1988;341-346.
71. Brämswig J.H., Hörnig-Franz I., Riepenhausen M., Schellong G. The challenge of pediatric Hodgkin's disease - where is the balance between cure and long-term toxicity? Leukemia and Lymphoma. 3:1990;183-193.
72. Oberlin O., Leverger G., Pacquement H.et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease. the experience of the French Society of Pediatric Oncology J. Clin. Oncol. 10:1992;1602-1608.
73. Schellong G., Riepenhausen M., Hörnig-Franz I.et al. Morbus Hodgkin bei kindern: kombinierte behandlungsstrategie mit involved-field-radiotherapie für die studien IA, IB und IIA. Klin. Onkol. 94/95:1994;62-66.
74. O'Brien M.E.R., Pinkterton C.R., Kingston J.et al. "VEEP" in children with Hodgkin's disease - a regimen to decrease late sequelae. Br. J. Cancer. 65:1992;756-760.
75. Landmann-Parker J, Oberlin O, Pacquement Y, et al. Localized childhood Hodgkin's disease: response adapted treatment by chemotherapy (CT) regimen with VP16, bleomycin, vinblastin and prednisone (VBVP) before low-dose radiation therapy (RT). Results of the study by the French Society of Pediatric Oncology (SFOP). Med Ped Oncol 1997, 29, Abstract O-135.
76. Kung FH, Behm FG, Falletta J, et al. Reduced dose chemoradiotherapy in early stage Hodgkin's disease of childhood. Med Ped Oncol 1993, 21, Abstract 58.
77. Dieckmann K, Pötter R, Heinzl H. Influence of bulky disease on local control in the German-Austrian Pediatric Hodgkin Study HD-90. Med Ped Oncol, 1997, 29, Abstract O-136.
78. Willmann K.Y., Cox R.S., Donaldson S.S. Radiation induced height impairment in pediatric Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 28:1993;85-94.
79. Behrendt H., Brinkhuis M., Van Leeuwen E.F. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy. Med. Pediatr. Oncol. 26:1996;244-248.
80. Martin J., Radford M. Current practice in Hodgkins Disease. The United Kingdom Children's Cancer Study Group. Kamps W.A., Humphrey G.B., Poppema S. Hodgkin's Disease in Children. Controversies and Current Practice:1989;263-275 Kluwer, Boston.
81. Ekert H., Waters K.D., Smith P.J.et al. Treatment with MOPP or ChIVPP chemotherapy only for all stages of childhood Hodgkin's disease. J. Clin. Oncol. 6:1988;1845-1850.
82. Chauvenet A, Gieser P, Kung F, et al. Pediatric Oncology Group (POG) Hodgkin's disease studies: experience with 630 children/adolescents treated with combined modality therapies from 1984-1993. Leukemia & Lymphoma 1998, 29, Abstract 0-7.
83. Leventhal B.G. Management of Stage I-II Hodgkin's disease in children. J. Clin. Oncol. 8:1990;1123-1124.
84. Dörffel W., Albrecht M., Lüders H.et al. Multinationale therapiestudie für den morbus Hodgkin bei kindern und jugendlichen GPOH-HD 95. Zwischenbericht nach 2 1/2 jahren. Klin. Pädiatrie. 210:1998;212-219.
85. Tesch H., Sieber M., Diehl V. Treatment of intermediate stages. Diehl V. Hodgkin's Disease. Baillière's Clinical Haematology Vol. 9, No. 3. 1996;543-551 Baillère Tindall, London.
86. Maity A., Goldwein J.W., Lange B., D'Angio G. Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease. an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania J. Clin. Oncol. 10:1992;929-993.
87. Rostock R.A., Siegelmann S.S., Lenhard R.E., Wharam M.D., Order S.E. Thoracic CT scanning for mediastinal Hodgkin's disease; results and therapeutic implications. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;1451-1457.
88. Bader S.B., Weinstein H., Mauch P., Silver B., Tarbell N.J. Pediatric stage IV Hodgin disease, long-term survival. Cancer. 72:1993;249-257.
89. Hunger S.P., Link M.P., Donaldson S.S. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease. the Stanford experience J. Clin. Oncol. 12:1994;2160-2166.
90. Oberlin O, Hörnig-Franz I, Pacquement H, et al. for the SIOP Hodgkin's Disease Study Group. Stage IV Hodgkin's disease: results of the study of the International Society of Paediatric Oncology. Abstract Fifth International Conference on Malignant Lymphoma. Lugano, 1993, 71.
91. Weiner M.A., Leventhal B., Brecher M.L.et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients. a Pediatric Oncology Group Study J. Clin. Oncol. 15:1997;2769-2779.
92. Donaldson S.S., Lamborn K.R. Radiation in pediatric Hodgkin's disease. J. Clin. Oncol. 16:1998;391-394.
93. Hörnig-Franz I, Schellong G, Riepenhausen M, Pötter R. Salvage therapy in Hodgkin's disease incorporating etoposide/ifosfamide/prednisone (IEP). A multi-center trial of the Geman Pediatric Study Group DAL-HD. Med Ped Oncol, 1992, 20, 441 (P198).
94. Schellong G., Hörnig I., Brämswig J.et al. Zur bedeutung des procarbazins in der chemotherapie des morbus Hodgkin - ein bericht der kooperativen therapiestudie DAL-HD-85. Klin. Pädiatr. 200:1988;205-213.
95. Gause B.L., Longo D.L. Treatment of relapsed Hodgkin's disease. Diehl V. Hodgkin's Disease. Baillière's Clinical Haematology Vol 9, No. 3 401-17. 1996;559-572 Baillère Tindall, London.
96. Williams C.D., Goldstone A.H., Pearce R.et al. Autologous bone marrow transplantation for paediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry. J. Clin. Oncol. 11:1993;2242-2249.